These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 29593912

  • 21. Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant Acinetobacter baumannii Isolates in a Hollow-Fibre Infection Model.
    Mohd Sazlly Lim S, Heffernan A, Naicker S, Wallis S, Roberts JA, Sime FB.
    Antibiotics (Basel); 2022 Nov 09; 11(11):. PubMed ID: 36358238
    [Abstract] [Full Text] [Related]

  • 22. In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital.
    Lertsrisatit Y, Santimaleeworagun W, Thunyaharn S, Traipattanakul J.
    Infect Drug Resist; 2017 Nov 09; 10():437-443. PubMed ID: 29200878
    [Abstract] [Full Text] [Related]

  • 23. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
    Ku YH, Chen CC, Lee MF, Chuang YC, Tang HJ, Yu WL.
    J Microbiol Immunol Infect; 2017 Dec 09; 50(6):931-939. PubMed ID: 28716360
    [Abstract] [Full Text] [Related]

  • 24. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an In Vitro Pharmacokinetic/Pharmacodynamic Model.
    Bian X, Liu X, Chen Y, Chen D, Li J, Zhang J.
    Antimicrob Agents Chemother; 2019 Apr 09; 63(4):. PubMed ID: 30745385
    [Abstract] [Full Text] [Related]

  • 25. In vitro activity of eravacycline in combination with colistin against carbapenem-resistant A. baumannii isolates.
    Ozger HS, Cuhadar T, Yildiz SS, Demirbas Gulmez Z, Dizbay M, Guzel Tunccan O, Kalkanci A, Simsek H, Unaldi O.
    J Antibiot (Tokyo); 2019 Aug 09; 72(8):600-604. PubMed ID: 31028352
    [Abstract] [Full Text] [Related]

  • 26. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Singkham-In U, Chatsuwan T.
    Diagn Microbiol Infect Dis; 2018 Jun 09; 91(2):169-174. PubMed ID: 29433997
    [Abstract] [Full Text] [Related]

  • 27. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii.
    Dong X, Chen F, Zhang Y, Liu H, Liu Y, Ma L.
    J Antibiot (Tokyo); 2014 Sep 09; 67(9):677-80. PubMed ID: 25095805
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.
    Peck KR, Kim MJ, Choi JY, Kim HS, Kang CI, Cho YK, Park DW, Lee HJ, Lee MS, Ko KS.
    J Med Microbiol; 2012 Mar 09; 61(Pt 3):353-360. PubMed ID: 22016557
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase.
    Wei W, Yang H, Liu Y, Ye Y, Li J.
    J Chemother; 2016 Jun 09; 28(3):159-63. PubMed ID: 25978105
    [Abstract] [Full Text] [Related]

  • 34. In vitro analysis of colistin-carbapenem combination activity against Acinetobacter spp infection.
    Soudeiha M, Sokhn ES, Daoud Z, Sarkis D.
    J Infect Dev Ctries; 2018 Feb 22; 12(2.1):11S. PubMed ID: 31804986
    [Abstract] [Full Text] [Related]

  • 35. In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods.
    Rodjun V, Houngsaitong J, Montakantikul P, Paiboonvong T, Khuntayaporn P, Yanyongchaikit P, Sriyant P.
    Antibiotics (Basel); 2020 Aug 14; 9(8):. PubMed ID: 32823820
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii.
    Percin D, Akyol S, Kalin G.
    GMS Hyg Infect Control; 2014 Aug 14; 9(2):Doc14. PubMed ID: 25152859
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.